GLOW Stack Protocol - BPC-157 + TB-500 + GHK-Cu

Quick Reference Dosing Card

What Is the GLOW Stack?

The GLOW Stack combines three peptides — BPC-157, TB-500, and GHK-Cu — to support both tissue repair and skin quality. Think of it as an upgrade to the Wolverine Stack: Wolverine handles the repair work, and GLOW adds a layer focused on how your skin and connective tissue look and feel afterward.

Each peptide plays a different role. BPC-157 supports blood vessel formation and protects tissue at the injury site. TB-500 helps repair cells move to where they're needed throughout the body. GHK-Cu — the addition that makes this the GLOW Stack — drives collagen and elastin production, which improves skin density, texture, and overall tissue quality.

No clinical trial has evaluated this three-peptide combination. Current protocols are based on individual-compound research and community usage patterns.

Why Add GHK-Cu to Wolverine?

Foundation: Wolverine (BPC-157 + TB-500)

The Wolverine Stack already provides two things your body needs after an injury: blood flow to the damaged area (BPC-157) and repair cells that can reach it (TB-500). GLOW keeps both of those pathways and adds a third.

Quality Layer: GHK-Cu

GHK-Cu is the reason this stack exists as a separate protocol. It uses copper to stimulate collagen and elastin production — the structural proteins that give skin its firmness and connective tissue its strength. GHK-Cu also influences how your body rebuilds the extracellular matrix (the scaffolding between cells), and it regulates a broad set of genes involved in tissue quality. The result: Wolverine helps you heal, and GHK-Cu helps you heal well — with better tissue quality rather than just patched-up damage.

Anti-Inflammatory Convergence

All three peptides reduce inflammation, but each works through a different pathway. Running them together creates overlapping anti-inflammatory coverage — similar to how combining ibuprofen and ice attacks swelling from two directions. This multi-layer approach may help create a better environment for repair.

Anti-Fibrotic Convergence

When tissue heals, the body can sometimes over-produce scar tissue (fibrosis). TB-500 and GHK-Cu together help balance this process — TB-500 organizes connective tissue formation while GHK-Cu manages the breakdown and replacement of old matrix material. The goal is cleaner, more organized healing rather than excessive scarring.

GLOW Stack Dosing Protocol & Schedule

• On TB-500 days, all three can be administered in one session using separate syringes.
• Separate-vial workflows preserve injury-site targeting for BPC-157 while keeping TB-500/GHK-Cu systemic.
• Pre-blended workflows reduce injection burden to one daily injection but limit independent dose control.

GLOW Stack Reconstitution Guide

• BPC-157 is dosed in micrograms; TB-500 and GHK-Cu are dosed in milligrams.
• Do not confuse mcg and mg dosing units across compounds; label every vial clearly.
• TB-500 is the shortest reconstituted stability window (1-2 weeks).
• GHK-Cu may show a slight blue/green tint after reconstitution.

Standard 7-Step Reconstitution (All Three)

1. Wipe stopper with alcohol and allow to dry.
2. Draw BAC water volume into sterile syringe.
3. Direct water against vial wall, not onto powder.
4. Allow gentle flow down the glass.
5. Roll 30-60 seconds; do not shake.
6. Inspect for expected clarity/color.
7. Label and refrigerate at 2-8C.

GLOW Stack Side Effects & Safety

Each of the three GLOW Stack peptides has a generally favorable safety profile in individual research, but no clinical trial has tested them as a combined stack.

What to watch for when running all three together:

Blood vessel growth (angiogenic) effects may overlap. BPC-157 and TB-500 both promote new blood vessel formation. Running them together means more angiogenic signaling than either one alone. This is generally considered positive for healing, but people with a history of conditions affected by blood vessel growth (such as certain cancers or retinal conditions) should be aware of this overlap.

GHK-Cu adds copper to your system. The copper in GHK-Cu is what drives its collagen benefits, but copper can accumulate over time. This is why GHK-Cu protocols include cycling — typically 30–60 days on followed by an equal period off. Skipping the off-cycle is the most common mistake with GHK-Cu.

Three compounds means three quality-control risks. Every additional peptide you source is another opportunity for contamination or underdosed product. Using COA-verified suppliers for all three compounds is more important with a multi-peptide stack than with a single-compound protocol.

Commonly reported GLOW Stack side effects:

• Injection-site irritation (redness, mild swelling — typically resolves in minutes)
• Short-term fatigue during the first 1–2 weeks of TB-500 loading
• Occasional headache, usually mild and transient

When to reassess: If injection-site reactions worsen rather than improve over the first week, if fatigue persists beyond the loading phase, or if you notice unusual symptoms, pause the protocol and consult a healthcare provider.

Clinical Evidence Context

Each peptide in the GLOW Stack has its own body of research, though the evidence level varies. BPC-157 has extensive animal and lab-based studies. TB-500 has some human safety data and early-stage (Phase II) clinical trial results. GHK-Cu has been studied both as a topical cream and at the molecular level, with published findings on collagen density improvement and gene-expression effects.

The reason researchers combine these three comes down to coverage: BPC-157 supports blood vessel formation at the repair site, TB-500 helps repair cells travel where they're needed, and GHK-Cu improves the quality of the tissue that gets rebuilt. Each covers a different stage of the healing process.

Storage & Handling

TB-500 remains the limiting reconstitution window in most separate-vial workflows.

GLOW vs Wolverine vs Individual Peptides

Not sure whether you need the full GLOW Stack, the simpler Wolverine Stack, or just one peptide on its own? The table below compares them across five key dimensions. The short version: choose GLOW if skin quality matters alongside repair, Wolverine if you want a simpler injury-focused protocol, or an individual peptide if you have a single, specific goal.

Related Stacking Protocols

GLOW + KPV

• Compounds: BPC-157 + TB-500 + GHK-Cu + KPV
• Rationale: KPV adds a dedicated anti-inflammatory peptide that works through the NF-kB pathway — one of the body's central inflammation switches. This extension (sometimes called the KLOW Stack) targets inflammation-heavy recovery scenarios.
• See KPV Protocol.

GLOW + GH Secretagogue

• Compounds: BPC-157 + TB-500 + GHK-Cu + CJC-1295/Ipamorelin
• Rationale: CJC-1295 and Ipamorelin stimulate your body's natural growth hormone release. Adding them to GLOW supports overnight recovery by timing GH pulses alongside the stack's repair and remodeling effects.

Frequently Asked Questions - GLOW Stack

Sources & Research

1. Vasireddi N, et al. "Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." Orthopaedic Journal of Sports Medicine, 2025.
2. Ruff D, et al. "A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers." Annals of the New York Academy of Sciences, 2010.
3. Pickart L, Margolina A "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." International Journal of Molecular Sciences, 2018 Link.
4. Bock-Marquette I, et al. "Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair." Nature, 2004.
5. Smart N, et al. "Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization." Nature, 2007.
6. Pickart L, et al. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." BioMed Research International, 2015 Link.
7. Yuvan Research / McGill University "Epigenetic mechanisms activated by GHK-Cu increase skin collagen density in clinical trial." EurekAlert, 2024.
8. Ehrlich HP, Hazard SW "Thymosin beta4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts." Annals of the New York Academy of Sciences, 2010.
9. Gwyer D, et al. "Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing." Cell and Tissue Research, 2019.
10. Philp D, et al. "Thymosin beta4 promotes angiogenesis, wound healing, and hair growth." FASEB Journal, 2004.
11. Sikiric P, et al. "The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity." Pharmaceuticals, 2024 Link.
12. Broad Institute Connectivity Map "Gene expression analysis of GHK-Cu." CLUE, 2024 Link.

Related Protocols

Disclaimer